Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru
    Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn Outcomes
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement Project
    Release Date:
    Partner: American Academy of Family Physicians
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enzalutamide in the Treatment of Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network, Astellas
    Review Process: Expert Review Panel
    Research Oncology USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Addressing Primary Immunodeficiencies within Minority/Underserved Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases
    Release Date:
    Partner: The Japan College of Rheumatology
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease
    Release Date:
    Partner: IHI
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Establishment of Support System for Healthy Life Extension of Patients with CV disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Racial and Ethnic Disparities in the Menopause Experience
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Immunotherapy in Urothelial Carcinoma
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology All
    Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    NSCLC Biomarker Testing
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
    Development of Talazoparib for Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network
    Review Process: Expert Review Panel
    Research Oncology USA
    Approaches to Smoking Cessation Counseling
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan
    Burden of Community Acquired Pneumonia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines USA
    Closing Knowledge Gaps in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Oncology USA
    Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer Patients
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Quality Improvement Oncology Japan
    ISID-Pfizer 2021 Grant Challenge
    Release Date:
    Partner: The International Society for Infectious Diseases (ISID)
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitors
    Release Date:
    Review Process: Expert Review Panel
    Research Oncology Portugal
    China Medical Education in Breast Cancer Diagnosis and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Hemophilia: Improve Knowledge Level of Gene Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    COVID-19 Epidemiology Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam
    Understanding Healthcare disparities in IBD Patients in Underserved Communities
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    Latin America Needs Assessment of Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Spanish (link)
    Translation: Mandarin (link)
    Translation: Arabic (link)
    Quality Improvement Rare Disease All
    Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antibiotic Stewardship in Pediatrics
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    China Educational Needs Assessment in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    China Medical Education in Atopic Dermatitis Awareness and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    Educational Activities to Improve Vaccination Rate beyond Clinical Departments
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Emerging Markets (Asia, Latin America, Africa, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Improving the Knowledge Gap on Vaccine Safety Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improve the Treatment Environment for Cancer Pain Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Promoting Pain Treatment in Osteoarthritis Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    Developing Clinical Research and Publication Skills(Asia, AfME, Latin America and China)
    Release Date:
    Partner: British Medical Journal (BMJ)
    Review Process: Expert Review Panel
    Education Internal Medicine All
    A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color
    Release Date:
    Partner: Conquer Cancer, The ASCO Foundation
    Review Process: Expert Review Panel
    Research Oncology USA
    PCF-Pfizer-Myovant Relugolix Challenge Awards
    Release Date:
    Partner: The Prostate Cancer Foundation and Myovant Sciences GmbH
    Review Process: Expert Review Panel
    Research Oncology USA
    BRAF-mutation Biomarker Testing in Colorectal Cancer and Melanoma
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Oncology Canada
    Pfizer Innovation Challenge: Patient Preference Database Blueprint
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Management of Uterine Fibroids and Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    COVID-19 Impact and SARS-CoV-2 Viral Lifecycle
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Addressing Knowledge Gaps on Biosimilar Use in Inflammatory Conditions
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Dermatology Research Fellowship in Skin of Color
    Release Date:
    Partner: Skin of Color Society
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All